The HealthTree Research articles are findings from HealthTree online surveys, from data inside the database, and from larger studies.
March 16, 2023
HealthTree Foundation and Adaptive joined forces to understand the awareness, knowledge, and perceptions of MRD testing among patients with multiple myeloma.
February 22, 2023
How do you make treatment decisions at myeloma relapse? Share your experience in our decision-making survey.
February 21, 2023
HealthTree developed a study that looked at how the number of medications used to treat myeloma affected the genetic risk of patients.
February 01, 2023
A HealthTree Research study shows adding another drug to a myeloma regimen did not increase the presence or severity of side effects.
August 22, 2022
Survey results from a study on nutrition perceptions and practices in myeloma patients.
July 26, 2022
A HealthTree Research study about genetic and imaging testing on myeloma patients.
June 14, 2022
The flood of bispecific antibodies is coming, with new data emerging from the recent EHA meeting
June 12, 2022
How important is your free light chain ratio when watching progression from smoldering myeloma to active myeloma? Dr. Theresia Akhlaghi shares new insights.
June 10, 2022
The European Hematology Association (EHA) conference has begun in Vienna, teaching us more about immunotherapy in myeloma
May 30, 2022
Understanding the psychosocial distress and unmet needs among myeloma patients during the pandemic.